研究单位：[1]Huashan Hospital[2]The First Affiliated Hospital of Fujian Medical University,Fuzhou,Fujian,China,350004[3]Quanzhou First Hospital,Quanzhou,Fujian,China,362000[4]The Fifth Affiliated Hospital of Sun Yat-sen University,Guangzhou,Guangdong,China,510000[5]Attached Hospital of Zunyi Medical College,Zunyi,Guizhou,China,563099[6]Huaihua First People's Hospital,Huaihua,Hunan,China,418000[7]Nanjing Hospital of Traditional Chinese Medicine,Nanjing,Jiangsu,China,210006[8]Affiliated Drum Tower Hospital, Medical School of Nanjing University,Nanjing,Jiangsu,China,210008[9]Wuxi Fifth People's Hospital,Wuxi,Jiangsu,China,214000[10]The People's Hospital Of Xingguo County,Ganzhou,Jiangxi,China,342400[11]The First Hospital of Shanxi Medical University,Taiyuan,Shanxi,China,030000[12]Affiliated Hospital of Southwest Medical University,Luzhou,Sichuan,China,646000[13]The First People's Hospital Of YunNan,Kunming,Yunnan,China,650100[14]People's Hospital of Qiubei County, Yunnan Province,Wenshan,Yunnan,China,663299[15]Hangzhou Linping District First People's Hospital,Hanzhou,Zhejiang,China,310000[16]Wenzhou Central Hospital,Wenzhou,Zhejiang,China,325099
This study is aimed to explore the dual-dimensional early intervention strategy of standard of care combined with host immunomodulation in elderly patients with mild and moderate COVID-19.
